Athersys (NASDAQ:ATHX) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX) in a research report released on Monday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.

Athersys Price Performance

NASDAQ:ATHX opened at $0.00 on Monday. Athersys has a 52 week low of $0.01 and a 52 week high of $1.99. The stock’s 50-day moving average price is $0.01 and its 200-day moving average price is $0.02. The stock has a market capitalization of $259,219.80, a PE ratio of 0.00 and a beta of -0.90.

Athersys Company Profile

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.